Consensus CervoMed Inc.

Equities

CRVO

US15713L1098

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
24.45 ^USD	-0.85%		+0.49%	+220.45%

Apr. 08	Canaccord Genuity Adjusts Price Target on CervoMed to $65 From $50, Maintains Buy Rating	MT
Mar. 29	CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Evolution of the average Target Price on CervoMed Inc.

Price target over the last 5 years

History of analyst recommendation changes

b985c962034507ae42c9.s1pD3Rghar0R95F8NkX4ScE4enyiqnhyThYukIZXBYA.5TkBmXxyD9V1k-EadTScfPFiFi_q_BAbHV8bxLIuNvD7OAGzR3Be6VSPyA~9b07b1d49f9ac68ed6205c1fd3276f57

Analyst Recommendations on CervoMed Inc.

Canaccord Genuity Adjusts Price Target on CervoMed to $65 From $50, Maintains Buy Rating	Apr. 08	MT
Canaccord Genuity Starts CervoMed With Buy Rating, $50 Price Target	Feb. 15	MT